Related Experiment Video
Updated: Jan 28, 2026
08:17
Generation of a Chronic Obstructive Pulmonary Disease Model in Mice by Repeated Ozone Exposure
Published on: August 25, 2017
11.5K
[Chronic cerebral ischemia in obstructive pulmonary diseases]
1Sechenov First Moscow State Medical University of the Ministry of Health of the Russian Federation, Moscow, Russia.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova
|March 5, 2019
Summary
Chronic obstructive pulmonary disease (COPD) can cause brain damage and neurological issues. Treating COPD patients with mexicor may improve outcomes for both brain and heart conditions.
Area of Science:
- Neurology
- Pulmonology
- Pharmacology
Background:
- Chronic obstructive pulmonary disease (COPD) is a leading global cause of mortality.
- COPD-induced tissue hypoxia affects nervous system function, leading to neurological deficits.
- Encephalopathy in COPD is a significant but understudied complication.
Purpose of the Study:
- To investigate the neurological consequences of COPD.
- To evaluate the potential of cytoprotective drugs in managing COPD-related encephalopathy.
- To assess the efficacy of mexicor in treating patients with COPD and associated cardiovascular conditions.
Main Methods:
- Review of neuroimaging studies on COPD patients.
- Pathogenetic justification for cytoprotective therapy in COPD.
- Clinical evaluation of mexicor's impact on chronic cerebral ischemia, cardiac insufficiency, and arrhythmia in COPD patients.
Main Results:
- Neuroimaging reveals white and grey matter damage and cerebral atrophy in COPD patients.
- Neurological symptoms, including cognitive and affective impairments, are linked to vascular lesions.
- Mexicor inclusion in COPD treatment enhances the management of both primary and secondary conditions.
Conclusions:
- Encephalopathy is a critical, under-recognized aspect of COPD.
- Cytoprotective agents like mexicor offer a pathogenetically sound approach to managing COPD complications.
- Mexicor demonstrates efficacy in improving outcomes for COPD patients with comorbid cerebral and cardiac issues.
Related Concept Videos
01:22Chronic Obstructive Pulmonary Disease
2.5K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
3.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.7K
01:29Chronic Obstructive Pulmonary Disease-V: Management
3.1K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
3.1K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
4.4K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
4.4K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
5.1K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
5.1K
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
3.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
3.7K